1. Home
  2. INTG vs SCYX Comparison

INTG vs SCYX Comparison

Compare INTG & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTG
  • SCYX
  • Stock Information
  • Founded
  • INTG 1965
  • SCYX 1999
  • Country
  • INTG United States
  • SCYX United States
  • Employees
  • INTG N/A
  • SCYX N/A
  • Industry
  • INTG Building operators
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTG Real Estate
  • SCYX Health Care
  • Exchange
  • INTG Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • INTG 24.0M
  • SCYX 26.6M
  • IPO Year
  • INTG N/A
  • SCYX 2014
  • Fundamental
  • Price
  • INTG $12.52
  • SCYX $0.84
  • Analyst Decision
  • INTG
  • SCYX
  • Analyst Count
  • INTG 0
  • SCYX 0
  • Target Price
  • INTG N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • INTG 3.5K
  • SCYX 195.8K
  • Earning Date
  • INTG 09-29-2025
  • SCYX 08-13-2025
  • Dividend Yield
  • INTG N/A
  • SCYX N/A
  • EPS Growth
  • INTG N/A
  • SCYX N/A
  • EPS
  • INTG N/A
  • SCYX N/A
  • Revenue
  • INTG $61,597,000.00
  • SCYX $3,257,000.00
  • Revenue This Year
  • INTG N/A
  • SCYX $410.22
  • Revenue Next Year
  • INTG N/A
  • SCYX $248.83
  • P/E Ratio
  • INTG N/A
  • SCYX N/A
  • Revenue Growth
  • INTG 6.76
  • SCYX N/A
  • 52 Week Low
  • INTG $9.57
  • SCYX $0.66
  • 52 Week High
  • INTG $19.24
  • SCYX $1.79
  • Technical
  • Relative Strength Index (RSI)
  • INTG 55.19
  • SCYX 59.11
  • Support Level
  • INTG $11.51
  • SCYX $0.68
  • Resistance Level
  • INTG $12.90
  • SCYX $0.88
  • Average True Range (ATR)
  • INTG 0.86
  • SCYX 0.05
  • MACD
  • INTG 0.19
  • SCYX 0.01
  • Stochastic Oscillator
  • INTG 73.75
  • SCYX 67.03

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: